Medicinershoppen ApS: Financial statements 2024
CVR: 40600434
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Medicinershoppen ApS (CVR 40600434) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 689,161 and a net result of DKK 158,971 compared with DKK 91,691 the year before. That is an increase of 38.9% compared with the year before. The profit margin was 23.1%. Equity in the 2024 report amounted to DKK 244,930. The solvency ratio was 81.4%.
- Revenue
- DKK 689,161
- Gross Profit
- DKK 212,698
- Profit/Loss
- DKK 158,971
- Equity
- DKK 244,930
- Total Assets
- DKK 300,867
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 689 t. | 213 t. | 159 t. | 245 t. | - |
| 2023 | 496 t. | 138 t. | 92 t. | 244 t. | - |
| 2022 | 509 t. | 51 t. | 40 t. | 251 t. | - |
| 2021 | 569 t. | 220 t. | 171 t. | 211 t. | - |
| 2020 | 257 t. | 84 t. | 62 t. | 102 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Medicinershoppen ApS has published its annual report for 2023. Revenue came to DKK 496,324, and the net result was DKK 91,691.
About Medicinershoppen ApS
Medicinershoppen ApS is a Danish company of the type Anpartsselskab based in Ribe, founded in 2019. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Martin Hollænder, Jacob Holmen Terkelsen and Kasper Bang Bredal. The company is owned by Martin Hollænder, Jacob Holmen Terkelsen and K. Bredal Invest ApS. In 2025, the company reported revenue of DKK 518,176 and a net result of DKK 118,512 compared with DKK 158,971 the year before. Equity in the 2025 report amounted to DKK 363,442.